BackView on Congress.gov
119th Congress•House

HR. 5343

Reported

Ensuring Patient Access to Critical Breakthrough Products Act

Latest action
2025-09-17
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Introduced
2025-09-15
Cosponsors
37
Origin
House
Subjects
Congressional oversightDrug safety, medical device, and laboratory regulationHealthHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesMedicare

Key actions

  1. 2025-09-17Committee
    Committee Consideration and Mark-up Session Held
  2. 2025-09-17Committee
    Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
  3. 2025-09-15IntroReferral
    Introduced in House
  4. 2025-09-15IntroReferral
    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. 2025-09-15IntroReferral
    Introduced in House

Bill text versions

Related bills

No related bills listed.